Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Just funded: Digital Sandbox KC ‘fuels innovation’ for five emerging tech startups
Scaling past the proof-of-concept stage is key for young startups, so making them fundable by the time their product is built can mean the difference between success and stagnation, said Jill Meyer, announcing the latest round of companies backed by Digital Sandbox KC. The five startups receiving up to $20,000 each include ventures focused on…
Coworking blueprint for contractors trades home for critical back-office business support
Trades CoWork provides a professional office environment, storage space, and back-office support to contractors and trades workers who have long been “dismissed,” said William Hayes, an entrepreneur who “sold everything” to fuel the venture. “There is nothing out there for the small contractors that gives them an affordable option to move out of their house,…
Why these Big Jay collectibles are a nod to bobblehead hall of fame’s love of KC-area sports
A cross-country childhood trip to the Negro Leagues Baseball Museum inspired a young baseball fan and rookie sports collector to keep Kansas City on his map — later incorporating an array of local major league and collegiate teams into his entrepreneurial venture: a national hall of fame for bobbleheads. The most recent additions to his…
Federal ban on noncompetes would ‘unleash’ entrepreneurs, open door to more startups, advocate says
A proposed rule change that would stop employers from imposing and enforcing contract clauses to limit their workers’ ability to change jobs within their fields is being hailed as a “vital step on the path to expanding economic growth in the United States,” according to one Kansas City-based advocate for entrepreneurs. Earlier this month, the…